INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED – Trademark Portfolio

Entity Type: 82

INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include POLYFROTH. The owner is based in BROOKLYN, VICTORIA.

BROOKLYN, VICTORIA 3012 , AU

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

POLYFROTH
POLYFROTH
Registered 2017

Trademark Classifications

INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED have?

INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED file in?

INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED's most well-known trademarks?

INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED's registered trademark portfolio includes well-known marks such as POLYFROTH. These are among 1 currently registered trademark in the portfolio.

What is INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED's trademark registration success rate?

INDORAMA VENTURES OXIDES AUSTRALIA PTY LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.